A new set of cloning vectors derived from pBlueScript (Stratagene, La
Jolla, CA, USA) is presented. The ampicillin-resistance-encoding gene
(Ap(R)) of pBlueScript has been replaced by genes encoding resistance
to either kanamycin (Km(R)) or tetracycline (Tc-R). The origin of DNA
replication (ori), conferring to pBlueScript a very high-copy-number (
500-700 copies/chromosome), has been replaced by the pBR322 ori (15-20
copies/chromosome) or the P15A ori (10-12 copies/chromosome) [Sambroo
k et al.: Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY, 1989]. Therefore, eig
ht new vectors with different drug selection markers and low, medium o
r high plasmid copy-number were created which are compatible with each
other (ColE1 ori and P15A ori) and can be selected to replace one ano
ther. These vectors were further modified by the insertion of an expre
ssion cassette based on the promoter and AraC repressor/activator of t
he ara operon, which allows high-level expression, extremely tight reg
ulation and very inexpensive induction. High-level expression of one o
r two genes within the same cell is demonstrated.